ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Psychiatry Prescribers in Massachusetts

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JUDITH HARAN M.D.

Psychiatry

5,514

$534K

235
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 20%

$97
Average prescription price

Avg: $110

XIANGYANG LI MD, PHD

Psychiatry

5,489

$492K

241
51 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 2%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 20%

$90
Average prescription price

Avg: $110

SANDRA FELDER M.D.

Psychiatry

5,475

$914K

326
48 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 20%

$167
Average prescription price

Avg: $110

MARIE HOBART M.D.

Psychiatry

5,414

$397K

229
35 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 20%

$73
Average prescription price

Avg: $110

PHILLIP HILL MD

Psychiatry

5,265

$519K

309
37 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 20%

$99
Average prescription price

Avg: $110

GEORGE HARDMAN MD

Psychiatry

5,228

$514K

294
37 are 65+

17%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 20%

$98
Average prescription price

Avg: $110

NECHAL TEJWANI MD

Psychiatry

5,199

$516K

362
85 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 20%

$99
Average prescription price

Avg: $110

ANNA FITZGERALD MD

Psychiatry

5,162

$355K

438
35 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

4%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 20%

$69
Average prescription price

Avg: $110

KATHERINE KIMI MIURA M.D.

Psychiatry

5,155

$602K

358
39 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 20%

$117
Average prescription price

Avg: $110

EMAD ESKANDER M.D.

Psychiatry

5,117

$546K

283
38 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 20%

$107
Average prescription price

Avg: $110

CHARU PATEL M.D.

Psychiatry

5,108

$487K

240
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 20%

$95
Average prescription price

Avg: $110

JOSHUA GOLDEN MD

Psychiatry

5,036

$642K

263
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 20%

$128
Average prescription price

Avg: $110

JULIANNE MILLER M.D.

Psychiatry

5,033

$516K

276
35 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 20%

$103
Average prescription price

Avg: $110

JAY STEARNS M.D.

Psychiatry

5,006

$566K

296
54 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 20%

$113
Average prescription price

Avg: $110

DOUGLAS GRIFFITHS M.D.

Psychiatry

5,001

$504K

304
28 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 20%

$101
Average prescription price

Avg: $110

STEVEN SPITZ M.D.

Psychiatry

4,981

$508K

176
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 20%

$102
Average prescription price

Avg: $110

RODOLFO RENI M.D.

Psychiatry

4,948

$547K

284
31 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 20%

$111
Average prescription price

Avg: $110

RICARDO DANCEL MD

Psychiatry

4,938

$420K

344
42 are 65+

14%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 20%

$85
Average prescription price

Avg: $110

ALVARO LOPEZ MD

Psychiatry

4,863

$569K

329
56 are 65+

16%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 20%

$117
Average prescription price

Avg: $110

KAREN SHEDLACK M.D.

Psychiatry

4,851

$413K

172
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 20%

$85
Average prescription price

Avg: $110

JOHN KANIA M.D.

Psychiatry

4,825

$511K

261
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 20%

$106
Average prescription price

Avg: $110

HERNANDO ROMERO MD

Psychiatry

4,812

$497K

215
42 are 65+

14%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 20%

$103
Average prescription price

Avg: $110

KENNETH TERKELSEN M.D.

Psychiatry

4,672

$519K

211
48 are 65+

19%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 20%

$111
Average prescription price

Avg: $110

SANGEETA BANERJEE M.D.

Psychiatry

4,601

$508K

190
35 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 20%

$110
Average prescription price

Avg: $110

PAUL WEISS M.D.

Psychiatry

4,540

$541K

228
30 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 20%

$119
Average prescription price

Avg: $110

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank